New disease modifying therapies for two genetic childhood-onset neurometabolic disorders (metachromatic leucodystrophy and adrenoleucodystrophy)
Crossref DOI link: https://doi.org/10.1007/s10072-021-05412-x
Published Online: 2021-07-01
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Federico, Antonio
de Visser, Marianne
Text and Data Mining valid from 2021-07-01
Version of Record valid from 2021-07-01
Article History
Accepted: 15 June 2021
First Online: 1 July 2021
Free to read: This content has been made available to all.